Schroder Investment Management Group
LEGN icon

Schroder Investment Management Group’s Legend Biotech LEGN Stock Holding History

Schroder Investment Management Group’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-66,955
Closed -$1.44M – 1228
2025
Q4 		$1.44M Sell
66,955
-61,108
-48% -$1.75M ﹤0.01% 942
2025
Q3 		$4.21M Sell
128,063
-61,954
-33% -$2.29M ﹤0.01% 800
2025
Q2 		$6.74M Sell
190,017
-37,983
-17% -$1.23M 0.01% 711
2025
Q1 		$7.99M Buy
228,000
+33,492
+17% +$1.2M 0.01% 677
2024
Q4 		$6.37M Buy
194,508
+83,191
+75% +$3.45M 0.01% 729
2024
Q3 		$5.48M Sell
111,317
-1,472
-1% -$78.4K 0.01% 770
2024
Q2 		$5M Sell
112,789
-1,937
-2% -$89.4K 0.01% 785
2024
Q1 		$6.43M Sell
114,726
-2,183
-2% -$132K 0.01% 735
2023
Q4 		$7.03M Buy
116,909
+33,812
+41% +$2.14M 0.01% 701
2023
Q3 		$5.58M Sell
83,097
-995
-1% -$69.1K 0.01% 727
2023
Q2 		$5.8M Sell
84,092
-4,272
-5% -$279K 0.01% 757
2023
Q1 		$4.26M Buy
88,364
+13,631
+18% +$667K 0.01% 815
2022
Q4 		$3.73M Buy
+74,733
New +$3.62M 0.01% 831

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.44B AUM 18.47% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Schroder Investment Management Group's LEGN Position: Q1 2026 in Review

Schroder Investment Management Group sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 66,955 shares — an estimated $1.44M sold.

Schroder Investment Management Group first reported a position in LEGN in Q4 2022 and held it in 13 quarters. The position peaked at $7.99M in Q1 2025. 191 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Schroder Investment Management Group reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
  • Schroder Investment Management Group sold 66,955 Legend Biotech shares in Q1 2026, an estimated $1.44M.
  • Schroder Investment Management Group first reported a position in Legend Biotech in Q4 2022 and held it in 13 quarters.
  • Schroder Investment Management Group's Legend Biotech position peaked at $7.99M in Q1 2025.
  • 191 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Schroder Investment Management Group's 13F filing for Q1 2026, filed 14 May 2026.